Project Grant HT94252410914
Award Date
8/15/24
Completion Date
8/14/27
Dollars Obligated
$949K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
The federal Project Grant award of $202,800.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai. The award, with a performance period from September 30, 2025 to September 29, 2026, supports advanced biomedical research focused on "Spatial Copy Number and Morphologic Alterations in Early Lung Carcinogenesis." This research aims to transform healthcare for...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,014,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The research, which is scheduled to take place from September 1, 2024 to August 31, 2028, will leverage the institution's expertise in areas such as cancer biology, immunology, and clinical...
The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
The federal Project Grant award of $437,420.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support advanced biomedical research by the Icahn School of Medicine at Mount Sinai (ISMMS) to transform healthcare for military service members and the broader public. The research aims to leverage personalized stem cell therapy to overcome airway reconstruction challenges. The award was granted on June 1, 2025 with an...
This $2,065,452 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the Icahn School of Medicine at Mount Sinai to investigate an "Epigenetic Innate Immune Memory Hypothesis for Gulf War Illness." The research aims to develop a diagnostic biomarker signature based on the pathophysiology of this condition. The award has a performance period from July 1, 2025 to June 30, 2028....
The Department of the Army Medical Command has awarded a $3,300,817 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai (ISMMS) in New York. This federal grant, with a performance period from June 1, 2025 to May 31, 2029, supports advanced biomedical research focused on leveraging personalized stem cell therapy to overcome airway reconstruction challenges. ISMMS, a prominent academic medical center and federal...
The Department of the Army Medical Command has awarded a $999,975.63 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Icahn School of Medicine at Mount Sinai. The award, effective April 1, 2025 through March 31, 2028, will support research on the "Molecular Mechanisms of APOE4 Vulnerability to Alzheimer's Disease and Identification of Novel Therapeutic Targets." This grant aims to advance biomedical research that can transform healthcare...
The Defense Health Agency awarded a $2,475,390.00 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2028, will fund a multifaceted intervention titled "MULTIFACETED INTERVENTION TO RESTORE RESILIENCE AND OVERCOME RISK (MIRROR)." As a renowned academic medical center, ISMMS will leverage its expertise in areas such as...
The Icahn School of Medicine at Mount Sinai will receive $1,521,002 under a three-year Project Grant award from the Defense Health Agency. The grant will support research from August 1, 2023 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). Specifically, the funding will enable research to determine the contribution of lineage intermediate tumor cells during progression to T-SCNC. This work aligns with the Military Medical Research and Development...